UBS Maintains Neutral on ArcBest, Raises Price Target to $122

Benzinga Newsdesk www.benzinga.com Neutral 50.8%

Neg 0% Neu 50.8% Pos 0%

UBS analyst Thomas Wadewitz maintains ArcBest (NASDAQ:ARCB) with a Neutral and raises the price target from $98 to $122.